Dr. S.K. Dash, adjunct professor at South Dakota State University, will present Selection Criteria for Probiotics at the upcoming International Probiotic Conference 2012 in San Antonio, Texas, on Nov. 19-21.
Human Microbiome Project spurs interest in probiotics
The recently released findings from the Human Microbiome Project have spurred increased interest in probiotics. A timely International Probiotic Scientific Conference is planned this year in San Antonio, Texas. The conference brings together an international mix of biotech companies, food processing companies and academia. The scientific program will focus on current advances in research, production and use of probiotics with a particular focus on their role in maintaining health and preventing disease.
Dr. S.K. Dash to present criteria for selection of probiotics
The functional qualities of probiotics relate to the specific strain of micro-organism and the production and handling of the probiotic. Dr. Dash has been a leader in the probiotic field since 1979 and as such has developed experience and knowledge into the properties of individual strains of probiotics as well as the specific requirements of manufacturing and handling probiotic strains. His presentation on Selection Criteria for Probiotics will address strain identity using genetic techniques and in vitro testing to establish probiotic qualities like acid and bile resistance, resistance to digestive enzymes, adherence to human epithelial cells, potential antimicrobial activity, affect on immune cytokines and sensitivity to common antibiotics. Different animal and human testing will be included. Dr. Dash will also describe stabilization techniques to ensure viability of probiotics throughout the supply chain along with Good Manufacturing Practices and considerations for condition-specific probiotic blends. The regulatory environment for probiotics continues to be an important consideration for selection, and Dr. Dash will address regulations in the U.S., European Union and Canada.
About UAS Laboratories, Inc.
UAS Laboratories, Inc. (Eden Prairie, MN USA), established in 1979, is one of the world’s leading biotechnology companies specializing in probiotic discovery, development, research, manufacture and marketing. The company manufactures products containing the trademarked, patented, Lactobacillus acidophilus DDS-1, a probiotic with over 200 studies. DDS Probiotics are sold to natural products retailers, health professionals, private label customers and as probiotic raw materials and customer specific blends to manufacturers in the US, and over 48 other countries. UAS Labs was founded by Dr. S.K. Dash, the probiotic pioneer, in 1979. Dr. Dash has previously served as a member of the Board of Directors, Vice President and as a member of the Scientific Advisory Board at the International Probiotic Association and is an Adjunct Professor of Nutrition and Food Science at South Dakota State University. Dr. Dash’s research and innovations in probiotics have earned 2010 Probiotic Award from Frost and Sullivan to UAS Labs and recognition from the Minnesota State Senate.